What is the recommended management for lithium toxicity, including indications for hemodialysis and supportive care?

Management of Lithium Toxicity

Stop lithium immediately, provide aggressive IV hydration, and initiate hemodialysis for severe toxicity (serum lithium >4.0 mEq/L, severe neurological symptoms, or renal failure), as hemodialysis is the most effective method for rapid lithium removal despite lack of randomized trial evidence 1, 2, 3.

Initial Management

Immediate Actions

• Discontinue lithium and all interacting medications (NSAIDs, ACE inhibitors, diuretics) 1
• Aggressive IV fluid resuscitation with normal saline to correct dehydration and enhance renal lithium clearance 1, 3
• Monitor electrolytes closely, particularly potassium and sodium 1
• Obtain serum lithium level and repeat every 4-6 hours until declining 3

Severity Classification

Toxicity severity correlates with both serum levels and clinical presentation:

• Mild: 1.5-2.5 mEq/L
• Moderate: 2.5-3.5 mEq/L
• Severe: >3.5 mEq/L 3

Critical caveat: Chronic toxicity and acute-on-chronic ingestion produce greater tissue accumulation and worse outcomes than acute overdose in lithium-naive patients, even at similar serum levels 2, 4. Tissue lithium concentrations lag behind serum levels, so clinical symptoms may worsen even as serum levels decline.

Indications for Hemodialysis

Hemodialysis should be initiated when any of the following are present 2, 3:

Absolute Indications

• Serum lithium >4.0 mEq/L
• Severe neurological symptoms (altered consciousness, seizures, coma, severe tremor)
• Acute kidney injury or chronic kidney disease with impaired lithium clearance
• Life-threatening cardiac arrhythmias

Relative Indications

• Serum lithium 2.5-4.0 mEq/L with moderate symptoms
• Chronic or acute-on-therapeutic toxicity with lithium >2.5 mEq/L 2
• Failure to improve with supportive care after 6-8 hours

Hemodialysis Technical Considerations

Intermittent hemodialysis (IHD) is the standard approach:

• Achieves lithium clearance of 160 ± 15 mL/min 5
• Reduces serum lithium half-life to 3.5 ± 0.8 hours (versus 29 hours with supportive care alone) 5
• Must anticipate rebound: Serum lithium often rebounds 6-12 hours post-dialysis due to redistribution from tissues 2, 3
• Repeat or prolonged dialysis (>16 hours) may be necessary to prevent rebound 2

Continuous renal replacement therapy (CRRT) is preferred when 6, 3:

• Hemodynamic instability precludes IHD
• Severe neurological symptoms require gradual, controlled removal
• Sustained treatment >16 hours allows complete body lithium removal without rebound 2, 6

Important pitfall: A single 4-hour hemodialysis session is often insufficient. Monitor post-dialysis lithium levels at 6 and 12 hours to detect rebound, and be prepared to dialyze again 2, 3.

Supportive Care Measures

Gastric Decontamination

• Gastric lavage may be considered if presentation is within 1 hour of acute ingestion 1
• Activated charcoal is not effective for lithium

Renal Enhancement

• IV normal saline is the cornerstone of supportive care 1, 3
• Diuretics do not improve lithium clearance beyond IV hydration alone and should be avoided 5
• Urea, mannitol, and aminophylline can increase lithium excretion but are rarely used in practice 1

Monitoring Requirements

• Serum lithium every 4-6 hours until consistently declining
• Renal function (creatinine, BUN) daily
• Electrolytes (especially sodium, potassium) every 6-12 hours
• ECG monitoring for conduction abnormalities
• Neurological examination serially for tremor, confusion, seizures

Clinical Manifestations to Monitor

Neurological (Most Common)

• Tremor, ataxia, dysarthria, confusion, seizures, coma 4, 3
• Permanent neurological sequelae can occur, particularly with chronic toxicity 2

Renal

• Nephrogenic diabetes insipidus (polyuria, polydipsia)
• Acute kidney injury
• Chronic tubulointerstitial nephropathy 7, 3

Cardiovascular

• Conduction abnormalities, arrhythmias, hypotension 3

Gastrointestinal

• Nausea, vomiting, diarrhea 3

Special Populations

Older Adults

• More vulnerable to toxicity even at therapeutic doses (mean toxic dose 675 mg/day in case series) 4
• Polypharmacy (63%) and medical comorbidities (76%) are major precipitating factors 4
• Lower threshold for hemodialysis consideration

Patients on Chronic Dialysis

• Lithium remains an option with careful dosing (typically 300-900 mg three times weekly post-dialysis) 8
• Monitor pre-dialysis levels closely for at least 2 weeks after initiation 8

Evidence Quality Note

No randomized controlled trials exist comparing hemodialysis to supportive care alone 9. The recommendation for hemodialysis is based on FDA drug labeling 1, pharmacokinetic principles, and consistent observational evidence showing effective lithium removal 2, 5, 3. The 2025 case report demonstrates successful use of continuous hemodialysis in severe intoxication 6, and the 2023 review provides current clinical recommendations 3.